Yahoo Finance

Manifold Bio's molecular 'barcodes' could break through pharma's in vivo bottleneck

In the creation of a new drug, there comes a point where you have to finally put the molecule in a real creature — one at a time — and see if it actually does what you think it does. Manifold Bio's ...
Business Wire

Manifold Bio Raises $40 Million Series A to Expand In Vivo Biologics Design Platform

BOSTON--(BUSINESS WIRE)--Manifold Bio, a next-generation protein therapeutics company pioneering an in vivo biologics design platform, today announced the close of a $40 million Series A financing ...
Morningstar

Manifold Bio Demonstrates Million-Scale Experimental Validation of AI-Driven Protein Binder Design with NVIDIA

Manifold Bio, a platform therapeutics company pioneering direct-to-vivo drug discovery, today announced a joint study with NVIDIA to validate Proteina-Complexa, NVIDIA's generative model for protein ...
The Boston Globe

George Church startup Manifold Bio raises $40m for ‘protein barcoding’ technology to improve drug testing

The Boston startup was spun out of George Church’s lab at Harvard Medical School with a more efficient way to test cancer drugs in animals Manifold Bio, a new startup founded by one of Boston’s most ...
Yahoo

Manifold Bio's molecular 'barcodes' could break through pharma's in vivo bottleneck

Add Yahoo as a preferred source to see more of our stories on Google. In the creation of a new drug, there comes a point where you have to finally put the molecule in a real creature — one at a time — ...